FREE Account Opening + No Clearing Fees
Loading...

Global Health Limited IPO (Global Health IPO) Detail

November 3, 2022 - November 7, 2022

Global Health IPO is a book built issue of Rs 2,205.57 crores. The issue comprises of fresh issue of Rs 500.00 crore and offer for sale of 5.08 crore shares.

Global Health IPO bidding started from November 3, 2022 and ended on November 7, 2022. The allotment for Global Health IPO was finalized on Friday, November 11, 2022. The shares got listed on BSE, NSE on November 16, 2022.

Global Health IPO price band is set at ₹319 to ₹336 per share. The minimum lot size for an application is 44 Shares. The minimum amount of investment required by retail investors is ₹14,784. The minimum lot size investment for sNII is 14 lots (616 shares), amounting to ₹206,976, and for bNII, it is 68 lots (2,992 shares), amounting to ₹1,005,312.

Kotak Mahindra Capital Company Limited, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited and Jm Financial Limited are the book running lead managers of the Global Health IPO, while Kfin Technologies Limited is the registrar for the issue.

Refer to Global Health IPO RHP for detailed information.

Global Health IPO Details

IPO Date November 3, 2022 to November 7, 2022
Listing Date November 16, 2022
Face Value ₹2 per share
Price Band ₹319 to ₹336 per share
Lot Size 44 Shares
Total Issue Size[.] shares
(aggregating up to ₹2,205.57 Cr)
Fresh Issue[.] shares
(aggregating up to ₹500.00 Cr)
Offer for Sale50,761,000 shares of ₹2
(aggregating up to ₹1,705.57 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE

Global Health IPO Reservation

Global Health IPO offers 46,742,397 shares. 13,524,905 (28.93%) to QIB, 9,965,248 (21.32%) to NII, 23,252,244 (49.75%) to RII. 528,460 RIIs will receive minimum 44 shares and 5,392 (sNII) and 10,784 (bNII) will receive minimum 616 shares. (in case of oversubscription)

Investor Category Shares OfferedMaximum Allottees
Anchor Investor Shares Offered-NA
QIB Shares Offered13,524,905 (28.93%)NA
NII (HNI) Shares Offered9,965,248 (21.32%)
  bNII > ₹10L6,643,498 (14.21%)10,784
  sNII < ₹10L3,321,750 (7.11%)5,392
Retail Shares Offered23,252,244 (49.75%)528,460
Total Shares Offered46,742,397 (100%)

Global Health IPO Timeline (Tentative Schedule)

Global Health IPO opens on November 3, 2022, and closes on November 7, 2022.

IPO Open Date Thursday, November 3, 2022
IPO Close Date Monday, November 7, 2022
Basis of Allotment Friday, November 11, 2022
Initiation of Refunds Monday, November 14, 2022
Credit of Shares to Demat Tuesday, November 15, 2022
Listing Date Wednesday, November 16, 2022
Cut-off time for UPI mandate confirmation 5 PM on November 7, 2022

Global Health IPO Lot Size

Investors can bid for a minimum of 44 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 44 ₹14,784
Retail (Max) 13 572 ₹192,192
S-HNI (Min) 14 616 ₹206,976
S-HNI (Max) 67 2,948 ₹990,528
B-HNI (Min) 68 2,992 ₹1,005,312
Lot Size Calculator

Global Health IPO Promoter Holding

Dr. Naresh Trehan is the company promoter.

Share Holding Pre Issue 35%
Share Holding Post Issue 33%

About Global Health Limited

Global Health Limited is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Limited have a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow) under the "Medanta" brand. The company established "The Medanta Institutional Tissue Repository" in 2017 to promote biomarker and other tissue-based research.

In Fiscals 2020, 2021 and 2022 and the three months ended June 30, 2021 and 2022, the company generated income from healthcare services of Rs. 14,805.71 million, Rs. 14,178.41 million, Rs. 21,003.95 million, Rs. 4,732.10 million and Rs. 5,960.89 226 million, respectively, and had EBITDA of Rs. 2,304.54 million, Rs. 2,228.52 million, Rs. 4,897.57 million, Rs. 1,057.69 million and Rs. 1,416.46 million, respectively.

As of June 30, 2022, the company provide healthcare services in over 30 medical specialities and engage over 1,300 doctors led by experienced department heads, spanning an area of 4.7 million sq. ft., the operational hospitals have 2,467 installed beds.

Global Health Limited's hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021 and 2022, and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 and was featured in the list of top 250 global hospitals in 2022 by Newsweek

Competitive Strengths:

  • Leading tertiary and quaternary care provider in India, well recognised for clinical expertise in particular in dealing with complicated cases.
  • Focus on Clinical Research and Academics.
  • Large-scale hospitals with world-class infrastructure, high-end medical equipment, and technology.
  • Track record of strong operational and financial performance.
  • Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna).
  • Growth opportunities in existing facilities and diversification into new services, including digital health.
  • Experienced senior management team with strong institutional shareholder support.

Company Financials

Global Health Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-202666.291544.2736.331349.54621.94
30-Jun-202855.11491.5841.761425.38725.07
31-Mar-212694.11478.1628.81382.34644.6
31-Mar-223145.522205.82196.21616.01837.86
30-Jun-223221.94626.5458.711675.55794.45
Amount in ₹ Crore

Key Performance Indicator

The market capitalization of Global Health IPO is Rs 9011.01 Cr.

Pre IPO Post IPO
P/E (x) 38.36

Objects of the Issue (Global Health IPO Objectives)

The company proposes to utilize the net proceeds of the Fresh Issue towards funding of the following objects:

1. Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.

2. General corporate purposes.

Global Health IPO Review (Apply)

[Dilip Davda]  GHL is operating under the most popular healthcare brand “Medanta” and posted growth over the years in its scale of operations. The issue is attractively priced based on its financial data and well compares with listed peers. Investors may consider an investment with medium to long-term perspectives. Read detail review...


Global Health IPO Subscription Status (Bidding Detail)

The Global Health IPO is subscribed 9.58 times on November 7, 2022 7:00:00 PM. The public issue subscribed 0.88 times in the retail category, 28.64 times in the QIB category, and 4.02 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)
QIB28.64
NII4.02
    bNII (bids above ₹10L)5.16
    sNII (bids below ₹10L)1.73
Retail0.88
Total9.58

Global Health IPO Prospectus

Global Health IPO Rating

543
4.0
Rating:Rated 4.0 stars
Vote Here ...

Global Health IPO Listing Details

Listing Date November 16, 2022
BSE Script Code 543654
NSE Symbol MEDANTA
ISIN INE474Q01031
Final Issue Price ₹336 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Open
Low
High
Last Trade
BSE
₹336.00
₹398.15
₹391.05
₹424.90
₹415.65
NSE
₹336.00
₹401.00
₹390.55
₹424.65
₹415.30

Check IPO Performance…

Global Health Limited Contact Details

Global Health Limited
Medanta – Mediclinic,
E-18, Defence Colony,
New Delhi, Delhi 110 024,
Phone: +91 124 483 4060
Email: compliance@medanta.org
Website: https://www.medanta.org/

Global Health IPO Registrar

Kfin Technologies Limited

Phone: 04067162222, 04079611000
Email: globalhealth.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/

Global Health IPO FAQs

Global Health IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹2,205.57 Crores. The issue is priced at ₹319 to ₹336 per share. The minimum order quantity is 44 Shares.

The IPO opens on November 3, 2022, and closes on November 7, 2022.

Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Global Health IPO using UPI as a payment gateway. Zerodha customers can apply in Global Health IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Global Health IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Global Health IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Global Health IPO opens on November 3, 2022 and closes on November 7, 2022.

Global Health IPO lot size is 44 Shares, and the minimum amount required is ₹14,784.

You can apply in Global Health IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Global Health IPO will be done on Friday, November 11, 2022, and the allotted shares will be credited to your demat account by Tuesday, November 15, 2022. Check the Global Health IPO allotment status.

The Global Health IPO listing date is on November 16, 2022.
Open an Instant Account with Zerodha

Global Health IPO Message Board

Ranked Members of Chittorgarh.com Forum  Ranked Members | Members with Most Likes

Loading...

745 Comments

316. lucky boy |   Link |  Bookmark |December 10, 2022 12:00:24 PM
IPO Mentor IPO Mentor (1100+ Posts, 400+ Likes)
grey market price main kissiko lena hain toah bindhas lele.... listing ke baad will move up
315. hchaturvedi |   Link |  Bookmark |November 24, 2022 8:49:08 AM
Today at 450 pls suggest already st 7.46 time of book value compare to Apollo PB 11.01
314. aspirant |   Link |  Bookmark |November 24, 2022 6:11:17 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
Any reason for up rise in share price? I guess it is because of some accumulation occurring due to insider info about good Q2 results declare.
313. Jaga |   Link |  Bookmark |November 23, 2022 2:29:15 PM
As said earlier soon it will touch UC
312. ssji |   Link |  Bookmark |November 21, 2022 10:36:25 AM
Why the share price has gone up today?.. any update?
312.1. I kHAN |   Link |  Bookmark |November 21, 2022 1:27:03 PM
Because I sold my last lot in the morning today :D :D
312.2. ssji |   Link |  Bookmark |November 22, 2022 8:50:06 AM
Ha Ha...
it is always happening to me. Need some expert advice on when to sell
311. Liger |   Link |  Bookmark |November 17, 2022 9:03:29 AM
Top Contributor Top Contributor (300+ Posts, 500+ Likes)
Why Retailers and GMP often fails to identify true potential of good companies like Sona Blw (Retail 1.5), Gland Pharma (Retail 0.24), Ruchi Soya FPO (Retail 0.9), Metro Brands (Retail 1.1), Aether Industries (Retail 1.14), Global Health (Retail 0.88) ??

All of them gave good gains post listing.
311.4. tusharahuja |   Link |  Bookmark |November 17, 2022 9:59:54 PM
Pls add five star business finance as well in the list ☺️
311.5. jajo |   Link |  Bookmark |November 17, 2022 10:36:47 PM
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
Out of the 8 main board IPOs of this month, I think companies with known brands like Bikaji, Medanta (Global) etc did better on listing. Similarly Rustomjee (Keystone) and possibly INOX are likely to do better on listing day.
310. kumar babu |   Link |  Bookmark |November 16, 2022 9:48:00 AM
What is the best price to enter newly...
310.6. DIVYANG ITO |   Link |  Bookmark |November 17, 2022 10:31:10 PM
Ok jaga bro , sorry bro for my rudeness
310.7. Jaga |   Link |  Bookmark |November 17, 2022 10:32:51 PM
higher range in medanta---correction in prev
309. Prabahar P M |   Link |  Bookmark |November 17, 2022 3:13:10 PM
Applied 3 lots each in Bikaji and Global. In Bikaji no allotment. In Global full 3 allotments. Very first day itselft applied 3 lots in Bikaji. But, First i thought to apply only one lot in Global. In last minute decided and applied 3 lots. Now in Bikaji less than 10% profit. But Global given me 25%, 30% and 35% profit in 3 lots. Market unpredictable.
308. SSingh |   Link |  Bookmark |November 15, 2022 4:26:28 AM
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
Seems like ₹400+ listing and within 1-2 months should cross ₹500 as well… All the best to allottees. Don’t sell in rush!
308.9. SSingh |   Link |  Bookmark |November 17, 2022 2:40:13 PM
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
Approx 60% of IPO shares have gone to strong hands. It might consolidate near 412-424 range but this is bound to cross 500 within a month!
I'm holding approx 5000+ shares with a strict stop loss of 400.
Sit Right, Hold Tight! (Motilal Tagline and they bought this gem themselves..)
Cheers...
308.10. SSingh |   Link |  Bookmark |November 17, 2022 3:02:59 PM
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
*Buy Right, Sit Tight!
Typo above…
307. Nirala |   Link |  Bookmark |November 16, 2022 2:19:35 PM
Ipo applied by UPI mandate comes under third party investment?because my application was rejected due to third party investment in medanta Ipo.Got mail today

Dear seniors kindly suggest
307.7. IPO MILNE WALA HAI😜 |   Link |  Bookmark |November 17, 2022 12:18:36 AM
Top Contributor Top Contributor (400+ Posts, 200+ Likes)
And @Nirala did you got the reason as REJECTED DUE TO TECHNICAL SOMETHING like this via email??
307.8. hchaturvedi |   Link |  Bookmark |November 17, 2022 2:39:27 PM
form where we can get this type of information
306. Jaga |   Link |  Bookmark |November 17, 2022 12:29:08 PM
Tomorrow it can touch UC
305. Param Patel |   Link |  Bookmark |November 16, 2022 5:46:13 PM
IPO Mentor IPO Mentor (700+ Posts, 400 Likes)
MOTILAL OSWAL MUTUAL FUND A/C MOTILAL OSWAL LONG TERM EQUITY FUND Bought 36,30,000 shares @ 401
NOMURA INDIA INVESTMENT FUND MOTHER FUND A/C Bought 15,00,000 shares @ 414.57
305.2. DIVYANG ITO |   Link |  Bookmark |November 16, 2022 8:00:35 PM
Param you deserve ipo guru tag for your findings, keep up the good work
305.3. hchaturvedi |   Link |  Bookmark |November 17, 2022 9:15:46 AM
current rate 436 with high of 454 can we keep it or sale
304. ValueSeeker |   Link |  Bookmark |November 17, 2022 8:02:54 AM
IPO Mentor IPO Mentor (1000+ Posts, 400+ Likes)
Motilal Oswal bought 36.3 lac Medanta shares in two schemes at 401, and Nomura bought 15 lac shares at 414.57 yesterday.
303. SUDHIRBHAI |   Link |  Bookmark |November 16, 2022 11:50:58 PM
Sold 13 lots at avg 403
302. Monster Zero |   Link |  Bookmark |November 16, 2022 2:32:53 PM
IPO Guru IPO Guru (3100+ Posts, 2800+ Likes)
People of chittorgarh and fellow new comers...
It is my astute observation than if you see these names under bulk deal on a new listed IPO, then be assured than they play only 1 part i.e to hold and support share price at a particular point. They could be hired or they must be doing it for trading purposes, but yes these securities do play a large part in holding shares prices For atleast first 3 days after ipo listing.

Names as follows

GRAVITON RESEARCH CAPITAL LLP
NK SECURITIES RESEARCH PRIVATE LIMITED
TWO ROADS TRADING PRIVATE LIMITED
MUSIGMA SECURITIES
GOLDMINE STOCKS PRIVATE LIMITED
NAMAN SECURITIES & FINANCE PVT LTD

After a few days the share price tends to fall and people are stuck.
Just an observation, not an acquisition.
302.6. pRACE |   Link |  Bookmark |November 16, 2022 3:38:57 PM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
yes checked the same on it. they have identical buy and sell qty at same rate, so looks like they do fake trading just to make us fool on total volume side...
302.7. jajo |   Link |  Bookmark |November 16, 2022 10:49:08 PM
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
@Monster Zero, Your observation is correct and it gives a good idea about the organised demand for price prop up thereby trapping investors. Thank you.
301. PLAZA |   Link |  Bookmark |November 16, 2022 2:22:21 PM
IPO Guru IPO Guru (1600+ Posts, 1100+ Likes)
sold all avg 408
301.1. AvinashUppalapati |   Link |  Bookmark |November 16, 2022 9:49:27 PM
Got 5 retail lots alloted

Sold all at avg of 405
300. Arun Jindal |   Link |  Bookmark |November 16, 2022 4:45:17 PM (200+ Posts)
I was and I am confident about Global hence I bought three hni lots. I will not sell even one share
299. Monster Zero |   Link |  Bookmark |November 16, 2022 2:11:35 PM
IPO Guru IPO Guru (3100+ Posts, 2800+ Likes)
Bought 125 @410
Sold 115 @415.4
Evening dinner.. Domino's medium pizza😂
299.2. DIVYANG ITO |   Link |  Bookmark |November 16, 2022 3:02:05 PM
My friend bought 200 at 416... What's ur take on medanta , in view of 2.5 days strategy in it
299.3. Monster Zero |   Link |  Bookmark |November 16, 2022 3:06:26 PM
IPO Guru IPO Guru (3100+ Posts, 2800+ Likes)
Before I placed my order...i compared it to rainbow children's hospital...
Looks like rainbow is a better buy due to similar p/e and higher margin.
I just placed order for a small swing
298. Innocent IPO Investor |   Link |  Bookmark |November 16, 2022 2:37:21 PM
jabardast listing of medanta.sell 1/3rd Qty hold rest for longterm. Congrats for all allotee.Happy listing
297. antarix |   Link |  Bookmark |November 16, 2022 8:47:34 AM
IPO Guru IPO Guru (1000+ Posts, 700+ Likes)
401
297.3. IPO VALSAD |   Link |  Bookmark |November 16, 2022 9:44:15 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
Aapke muh me ghee shakkar antrixji...
297.4. NARESH PATEL |   Link |  Bookmark |November 16, 2022 1:27:45 PM
Hai naa abhy Dusaraa aisaa RUSTOMJEE....